Who will read my blog?

It is essential to consider your audience when writing a blog so that the content resonates with the reader. The BIA community consists of a wide range of innovative life sciences and biotech companies, as well as industry stakeholders including government, policymakers, professional bodies and journalists in the UK and beyond. 

All blogs are published in the blog section of the BIA website. Our website is visited by 172,000 users, generating 465,000 page views annually from across the UK (44%), United States (20%), Europe (16%), China (7%) and India (4%).

Guest blogs are often featured in our e-news - Newscast, with nearly 10,000 subscribers, and Member Insights reserved exclusively for BIA members with over 4,000 recipients.

We also promote guest blogs across our social media channels - LinkedInTwitter and YouTube (over 25,000 followers combined).

How should I write my blog?

Popular guest blog topics address subjects that appeal to our audience, we welcome topics surrounding access to medicines, finance/tax investment, overarching political issues, techbio, pre-clinical and clinical research, manufacturing, strategic technologies, regulatory landscapes, skills, diversity and more!

Top tips:

  • Address a clear and compelling subject: having a punchy headline and introduction will grab the reader’s attention.
  • Explain the subject to the reader: some readers will be interested in the minutiae of the issues and will require an in-depth explanation. Using hyperlinks to other blogs, articles, reports, websites, or briefings that have this detail will be beneficial.
  • Explain your connection to the topic: blogging is often a more personal form of writing, connect with your audience by demonstrating your link to and expertise on the blog’s content.
  • Include images and visuals: images can be very useful in helping you tell a story or explain a concept, so try to include at least one or two photos or images. Please ensure you have the right to use these photos to avoid copyright infringement.
  • Provide a headshot of the author: having a headshot-like photo of yourself is also important. The author's photo helps readers connect with you. It needs to be professional, clean, and actually looks like you. If readers know what you look like, they can find you at events.
  • Be concise: between 500-800 words, or one/one and a half A4.

Please note that we do not accept any over-promotional blogs.

How do I submit my blog?

Please send your blog to Alina and Erica at least three days before it is due to be published. This will give us an opportunity to proofread and come up with any suggestions we think may enhance your content.

View examples of guest blogs

CEO Update | 27 March 2023

The UK Government published last week the long-awaited response to the consultation on proposals to improve the UK clinical trials legislation, with a foreword by life science champions Sir John Bell and Sir Jon Symonds. These reforms represent the biggest overhaul in UK clinical trials regulation in over 20 years and will make the UK one of the best countries to conduct clinical research for the benefit of patients and the life sciences sector. Continue reading for details on upcoming events, UK Parliament scrutiny of SVB Collapse, and more.

Revolutionising healthcare with data-driven innovation

Meet Danny Bosch, Associate Director of Business Development and Commercial at Imperial College Health Partners (ICHP). In his blog, Danny details how ICHP are working towards creating healthier populations, by unlocking the potential of innovation and supporting NHS and industry. 

Unlocking the power of Virtual Reality to overcome anxiety and phobias

XR Therapeutics is a start-up company, spun out of Newcastle University, helping people to overcome their phobias or anxiety using Virtual Reality technology. We spoke with Penny Day, Head of Operations, about the role of virtual reality in mental health treatment, and how XR is making waves in this space.

CEO Update | 20 March 2023

The Budget last week had major wins for BIA members including changes to R&D tax credits rates for loss-making SMEs. Read our press release and Martin’s analysis blog. This is a major, major win for a BIA campaign and wouldn’t have happened without member engagement and perseverance. Many thanks to all who helped – this non dilutive government co-investment will make all the difference as you crowd in private sector investment.